nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Back pain—Fingolimod—multiple sclerosis	0.00889	0.0125	CcSEcCtD
Midodrine—Hepatic enzyme increased—Mitoxantrone—multiple sclerosis	0.00828	0.0117	CcSEcCtD
Midodrine—Hepatic function abnormal—Azathioprine—multiple sclerosis	0.00805	0.0113	CcSEcCtD
Midodrine—Hypertension—Fingolimod—multiple sclerosis	0.00794	0.0112	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00777	0.0109	CcSEcCtD
Midodrine—Nervous system disorder—Fingolimod—multiple sclerosis	0.00736	0.0104	CcSEcCtD
Midodrine—Skin disorder—Fingolimod—multiple sclerosis	0.00729	0.0103	CcSEcCtD
Midodrine—Abdominal discomfort—Cladribine—multiple sclerosis	0.00717	0.0101	CcSEcCtD
Midodrine—Paraesthesia—Fingolimod—multiple sclerosis	0.00674	0.00948	CcSEcCtD
Midodrine—Dyspnoea—Fingolimod—multiple sclerosis	0.00669	0.00942	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.00661	0.00931	CcSEcCtD
Midodrine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00648	0.00912	CcSEcCtD
Midodrine—Hepatobiliary disease—Cladribine—multiple sclerosis	0.00631	0.00888	CcSEcCtD
Midodrine—Urinary tract disorder—Cladribine—multiple sclerosis	0.00591	0.00832	CcSEcCtD
Midodrine—Urethral disorder—Cladribine—multiple sclerosis	0.00587	0.00826	CcSEcCtD
Midodrine—Abdominal discomfort—Azathioprine—multiple sclerosis	0.00583	0.00821	CcSEcCtD
Midodrine—Erythema multiforme—Cladribine—multiple sclerosis	0.00566	0.00797	CcSEcCtD
Midodrine—Cardiac disorder—Cladribine—multiple sclerosis	0.00556	0.00782	CcSEcCtD
Midodrine—Angiopathy—Cladribine—multiple sclerosis	0.00543	0.00765	CcSEcCtD
Midodrine—Asthenia—Fingolimod—multiple sclerosis	0.00538	0.00758	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00538	0.00757	CcSEcCtD
Midodrine—Chills—Cladribine—multiple sclerosis	0.00537	0.00756	CcSEcCtD
Midodrine—Pruritus—Fingolimod—multiple sclerosis	0.00531	0.00747	CcSEcCtD
Midodrine—Mental disorder—Cladribine—multiple sclerosis	0.00524	0.00738	CcSEcCtD
Midodrine—Flatulence—Cladribine—multiple sclerosis	0.00514	0.00723	CcSEcCtD
Midodrine—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.00513	0.00722	CcSEcCtD
Midodrine—Back pain—Cladribine—multiple sclerosis	0.00504	0.0071	CcSEcCtD
Midodrine—Dizziness—Fingolimod—multiple sclerosis	0.00496	0.00698	CcSEcCtD
Midodrine—Headache—Fingolimod—multiple sclerosis	0.0047	0.00662	CcSEcCtD
Midodrine—Erythema multiforme—Azathioprine—multiple sclerosis	0.0046	0.00648	CcSEcCtD
Midodrine—Anxiety—Cladribine—multiple sclerosis	0.00442	0.00622	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00441	0.0062	CcSEcCtD
Midodrine—Chills—Azathioprine—multiple sclerosis	0.00437	0.00615	CcSEcCtD
Midodrine—Confusional state—Cladribine—multiple sclerosis	0.00429	0.00604	CcSEcCtD
Midodrine—Dry skin—Prednisolone—multiple sclerosis	0.00428	0.00602	CcSEcCtD
Midodrine—Stomatitis—Mitoxantrone—multiple sclerosis	0.00427	0.00601	CcSEcCtD
Midodrine—Nervous system disorder—Cladribine—multiple sclerosis	0.00417	0.00587	CcSEcCtD
Midodrine—Tachycardia—Cladribine—multiple sclerosis	0.00415	0.00584	CcSEcCtD
Midodrine—Skin disorder—Cladribine—multiple sclerosis	0.00413	0.00581	CcSEcCtD
Midodrine—Hepatic enzyme increased—Methotrexate—multiple sclerosis	0.00413	0.00581	CcSEcCtD
Midodrine—Irritability—Methylprednisolone—multiple sclerosis	0.00409	0.00575	CcSEcCtD
Midodrine—Bradycardia—Mitoxantrone—multiple sclerosis	0.00401	0.00564	CcSEcCtD
Midodrine—Insomnia—Cladribine—multiple sclerosis	0.00385	0.00541	CcSEcCtD
Midodrine—Paraesthesia—Cladribine—multiple sclerosis	0.00382	0.00538	CcSEcCtD
Midodrine—Dyspnoea—Cladribine—multiple sclerosis	0.00379	0.00534	CcSEcCtD
Midodrine—Somnolence—Cladribine—multiple sclerosis	0.00378	0.00532	CcSEcCtD
Midodrine—Irritability—Betamethasone—multiple sclerosis	0.00372	0.00523	CcSEcCtD
Midodrine—Irritability—Dexamethasone—multiple sclerosis	0.00372	0.00523	CcSEcCtD
Midodrine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00367	0.00517	CcSEcCtD
Midodrine—Pain—Cladribine—multiple sclerosis	0.00364	0.00512	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00358	0.00504	CcSEcCtD
Midodrine—Dry skin—Dexamethasone—multiple sclerosis	0.00357	0.00502	CcSEcCtD
Midodrine—Dry skin—Betamethasone—multiple sclerosis	0.00357	0.00502	CcSEcCtD
Midodrine—Chills—Mitoxantrone—multiple sclerosis	0.00353	0.00497	CcSEcCtD
Midodrine—Feeling abnormal—Cladribine—multiple sclerosis	0.0035	0.00493	CcSEcCtD
Midodrine—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00348	0.0049	CcSEcCtD
Midodrine—Abdominal pain—Cladribine—multiple sclerosis	0.00336	0.00473	CcSEcCtD
Midodrine—Skin disorder—Azathioprine—multiple sclerosis	0.00336	0.00473	CcSEcCtD
Midodrine—Back pain—Mitoxantrone—multiple sclerosis	0.00331	0.00466	CcSEcCtD
Midodrine—Bradycardia—Prednisolone—multiple sclerosis	0.00329	0.00463	CcSEcCtD
Midodrine—Irritability—Prednisone—multiple sclerosis	0.00324	0.00456	CcSEcCtD
Midodrine—Dry skin—Prednisone—multiple sclerosis	0.00311	0.00437	CcSEcCtD
Midodrine—Asthenia—Cladribine—multiple sclerosis	0.00305	0.0043	CcSEcCtD
Midodrine—Bradycardia—Triamcinolone—multiple sclerosis	0.00302	0.00425	CcSEcCtD
Midodrine—Bradycardia—Methylprednisolone—multiple sclerosis	0.00302	0.00424	CcSEcCtD
Midodrine—Pruritus—Cladribine—multiple sclerosis	0.00301	0.00424	CcSEcCtD
Midodrine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00299	0.0042	CcSEcCtD
Midodrine—Hypertension—Mitoxantrone—multiple sclerosis	0.00296	0.00416	CcSEcCtD
Midodrine—Anxiety—Mitoxantrone—multiple sclerosis	0.00291	0.00409	CcSEcCtD
Midodrine—Feeling abnormal—Azathioprine—multiple sclerosis	0.00285	0.00401	CcSEcCtD
Midodrine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00283	0.00398	CcSEcCtD
Midodrine—Confusional state—Mitoxantrone—multiple sclerosis	0.00282	0.00397	CcSEcCtD
Midodrine—Dizziness—Cladribine—multiple sclerosis	0.00281	0.00396	CcSEcCtD
Midodrine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.00275	0.00387	CcSEcCtD
Midodrine—Bradycardia—Betamethasone—multiple sclerosis	0.00274	0.00386	CcSEcCtD
Midodrine—Bradycardia—Dexamethasone—multiple sclerosis	0.00274	0.00386	CcSEcCtD
Midodrine—Abdominal pain—Azathioprine—multiple sclerosis	0.00273	0.00385	CcSEcCtD
Midodrine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00273	0.00384	CcSEcCtD
Midodrine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00272	0.00382	CcSEcCtD
Midodrine—Irritability—Methotrexate—multiple sclerosis	0.0027	0.00381	CcSEcCtD
Midodrine—Angiopathy—Methylprednisolone—multiple sclerosis	0.00269	0.00378	CcSEcCtD
Midodrine—Rash—Cladribine—multiple sclerosis	0.00268	0.00377	CcSEcCtD
Midodrine—Dermatitis—Cladribine—multiple sclerosis	0.00268	0.00377	CcSEcCtD
Midodrine—Headache—Cladribine—multiple sclerosis	0.00266	0.00375	CcSEcCtD
Midodrine—Mental disorder—Methylprednisolone—multiple sclerosis	0.0026	0.00365	CcSEcCtD
Midodrine—Nausea—Cladribine—multiple sclerosis	0.00253	0.00356	CcSEcCtD
Midodrine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00251	0.00353	CcSEcCtD
Midodrine—Back pain—Triamcinolone—multiple sclerosis	0.0025	0.00352	CcSEcCtD
Midodrine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00249	0.00351	CcSEcCtD
Midodrine—Somnolence—Mitoxantrone—multiple sclerosis	0.00249	0.0035	CcSEcCtD
Midodrine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00246	0.00346	CcSEcCtD
Midodrine—Angiopathy—Betamethasone—multiple sclerosis	0.00244	0.00344	CcSEcCtD
Midodrine—Angiopathy—Dexamethasone—multiple sclerosis	0.00244	0.00344	CcSEcCtD
Midodrine—Hypertension—Prednisolone—multiple sclerosis	0.00243	0.00342	CcSEcCtD
Midodrine—Pain—Mitoxantrone—multiple sclerosis	0.00239	0.00336	CcSEcCtD
Midodrine—Bradycardia—Prednisone—multiple sclerosis	0.00239	0.00336	CcSEcCtD
Midodrine—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00235	0.00331	CcSEcCtD
Midodrine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.0023	0.00324	CcSEcCtD
Midodrine—Dysuria—Methotrexate—multiple sclerosis	0.00229	0.00322	CcSEcCtD
Midodrine—Dizziness—Azathioprine—multiple sclerosis	0.00229	0.00322	CcSEcCtD
Midodrine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00229	0.00322	CcSEcCtD
Midodrine—Tachycardia—Prednisolone—multiple sclerosis	0.00224	0.00315	CcSEcCtD
Midodrine—Hypertension—Triamcinolone—multiple sclerosis	0.00223	0.00314	CcSEcCtD
Midodrine—Hypertension—Methylprednisolone—multiple sclerosis	0.00223	0.00313	CcSEcCtD
Midodrine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00221	0.00311	CcSEcCtD
Midodrine—Anxiety—Methylprednisolone—multiple sclerosis	0.00219	0.00308	CcSEcCtD
Midodrine—Rash—Azathioprine—multiple sclerosis	0.00218	0.00307	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00218	0.00307	CcSEcCtD
Midodrine—Dermatitis—Azathioprine—multiple sclerosis	0.00218	0.00307	CcSEcCtD
Midodrine—Flushing—Prednisone—multiple sclerosis	0.00218	0.00306	CcSEcCtD
Midodrine—Headache—Azathioprine—multiple sclerosis	0.00217	0.00305	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00217	0.00305	CcSEcCtD
Midodrine—Dry mouth—Triamcinolone—multiple sclerosis	0.00215	0.00303	CcSEcCtD
Midodrine—Stomatitis—Methotrexate—multiple sclerosis	0.00213	0.003	CcSEcCtD
Midodrine—Angiopathy—Prednisone—multiple sclerosis	0.00213	0.003	CcSEcCtD
Midodrine—Confusional state—Methylprednisolone—multiple sclerosis	0.00212	0.00299	CcSEcCtD
Midodrine—Insomnia—Prednisolone—multiple sclerosis	0.00207	0.00292	CcSEcCtD
Midodrine—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00207	0.00291	CcSEcCtD
Midodrine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00206	0.0029	CcSEcCtD
Midodrine—Paraesthesia—Prednisolone—multiple sclerosis	0.00206	0.0029	CcSEcCtD
Midodrine—Tachycardia—Triamcinolone—multiple sclerosis	0.00206	0.0029	CcSEcCtD
Midodrine—Mental disorder—Prednisone—multiple sclerosis	0.00206	0.00289	CcSEcCtD
Midodrine—Nausea—Azathioprine—multiple sclerosis	0.00205	0.00289	CcSEcCtD
Midodrine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00205	0.00289	CcSEcCtD
Midodrine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00204	0.00288	CcSEcCtD
Midodrine—Hypertension—Dexamethasone—multiple sclerosis	0.00202	0.00285	CcSEcCtD
Midodrine—Hypertension—Betamethasone—multiple sclerosis	0.00202	0.00285	CcSEcCtD
Midodrine—Asthenia—Mitoxantrone—multiple sclerosis	0.00201	0.00282	CcSEcCtD
Midodrine—Anxiety—Dexamethasone—multiple sclerosis	0.00199	0.0028	CcSEcCtD
Midodrine—Anxiety—Betamethasone—multiple sclerosis	0.00199	0.0028	CcSEcCtD
Midodrine—Pain—Prednisolone—multiple sclerosis	0.00196	0.00276	CcSEcCtD
Midodrine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00194	0.00273	CcSEcCtD
Midodrine—Urethral disorder—Methotrexate—multiple sclerosis	0.00192	0.00271	CcSEcCtD
Midodrine—Insomnia—Triamcinolone—multiple sclerosis	0.00191	0.00269	CcSEcCtD
Midodrine—Insomnia—Methylprednisolone—multiple sclerosis	0.0019	0.00268	CcSEcCtD
Midodrine—Paraesthesia—Triamcinolone—multiple sclerosis	0.00189	0.00267	CcSEcCtD
Midodrine—Feeling abnormal—Prednisolone—multiple sclerosis	0.00189	0.00266	CcSEcCtD
Midodrine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00189	0.00266	CcSEcCtD
Midodrine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00188	0.00265	CcSEcCtD
Midodrine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00188	0.00264	CcSEcCtD
Midodrine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00188	0.00264	CcSEcCtD
Midodrine—Agitation—Prednisone—multiple sclerosis	0.00188	0.00264	CcSEcCtD
Midodrine—Tachycardia—Betamethasone—multiple sclerosis	0.00187	0.00263	CcSEcCtD
Midodrine—Tachycardia—Dexamethasone—multiple sclerosis	0.00187	0.00263	CcSEcCtD
Midodrine—Dyspepsia—Triamcinolone—multiple sclerosis	0.00186	0.00261	CcSEcCtD
Midodrine—Erythema multiforme—Methotrexate—multiple sclerosis	0.00185	0.00261	CcSEcCtD
Midodrine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00185	0.00261	CcSEcCtD
Midodrine—Cardiac disorder—Methotrexate—multiple sclerosis	0.00182	0.00256	CcSEcCtD
Midodrine—Pain—Triamcinolone—multiple sclerosis	0.0018	0.00254	CcSEcCtD
Midodrine—Angiopathy—Methotrexate—multiple sclerosis	0.00178	0.0025	CcSEcCtD
Midodrine—Hypertension—Prednisone—multiple sclerosis	0.00176	0.00248	CcSEcCtD
Midodrine—Rash—Mitoxantrone—multiple sclerosis	0.00176	0.00248	CcSEcCtD
Midodrine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00176	0.00248	CcSEcCtD
Midodrine—Chills—Methotrexate—multiple sclerosis	0.00176	0.00248	CcSEcCtD
Midodrine—Headache—Mitoxantrone—multiple sclerosis	0.00175	0.00247	CcSEcCtD
Midodrine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00174	0.00245	CcSEcCtD
Midodrine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00173	0.00244	CcSEcCtD
Midodrine—Anxiety—Prednisone—multiple sclerosis	0.00173	0.00244	CcSEcCtD
Midodrine—Insomnia—Betamethasone—multiple sclerosis	0.00173	0.00244	CcSEcCtD
Midodrine—Insomnia—Dexamethasone—multiple sclerosis	0.00173	0.00244	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00173	0.00243	CcSEcCtD
Midodrine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00172	0.00242	CcSEcCtD
Midodrine—Paraesthesia—Dexamethasone—multiple sclerosis	0.00172	0.00242	CcSEcCtD
Midodrine—Paraesthesia—Betamethasone—multiple sclerosis	0.00172	0.00242	CcSEcCtD
Midodrine—Mental disorder—Methotrexate—multiple sclerosis	0.00172	0.00242	CcSEcCtD
Midodrine—Dyspepsia—Betamethasone—multiple sclerosis	0.00168	0.00237	CcSEcCtD
Midodrine—Dyspepsia—Dexamethasone—multiple sclerosis	0.00168	0.00237	CcSEcCtD
Midodrine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00166	0.00234	CcSEcCtD
Midodrine—Nausea—Mitoxantrone—multiple sclerosis	0.00166	0.00234	CcSEcCtD
Midodrine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00165	0.00233	CcSEcCtD
Midodrine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00165	0.00233	CcSEcCtD
Midodrine—Back pain—Methotrexate—multiple sclerosis	0.00165	0.00232	CcSEcCtD
Midodrine—Pain—Betamethasone—multiple sclerosis	0.00164	0.0023	CcSEcCtD
Midodrine—Pain—Dexamethasone—multiple sclerosis	0.00164	0.0023	CcSEcCtD
Midodrine—Nervous system disorder—Prednisone—multiple sclerosis	0.00163	0.0023	CcSEcCtD
Midodrine—Tachycardia—Prednisone—multiple sclerosis	0.00163	0.00229	CcSEcCtD
Midodrine—Skin disorder—Prednisone—multiple sclerosis	0.00162	0.00228	CcSEcCtD
Midodrine—Feeling abnormal—Betamethasone—multiple sclerosis	0.00158	0.00222	CcSEcCtD
Midodrine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00158	0.00222	CcSEcCtD
Midodrine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00156	0.0022	CcSEcCtD
Midodrine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00156	0.0022	CcSEcCtD
Midodrine—Dizziness—Prednisolone—multiple sclerosis	0.00152	0.00213	CcSEcCtD
Midodrine—Asthenia—Triamcinolone—multiple sclerosis	0.00151	0.00213	CcSEcCtD
Midodrine—Abdominal pain—Dexamethasone—multiple sclerosis	0.00151	0.00213	CcSEcCtD
Midodrine—Abdominal pain—Betamethasone—multiple sclerosis	0.00151	0.00213	CcSEcCtD
Midodrine—Asthenia—Methylprednisolone—multiple sclerosis	0.00151	0.00213	CcSEcCtD
Midodrine—Insomnia—Prednisone—multiple sclerosis	0.00151	0.00212	CcSEcCtD
Midodrine—Paraesthesia—Prednisone—multiple sclerosis	0.0015	0.00211	CcSEcCtD
Midodrine—Pruritus—Triamcinolone—multiple sclerosis	0.00149	0.0021	CcSEcCtD
Midodrine—Pruritus—Methylprednisolone—multiple sclerosis	0.00149	0.0021	CcSEcCtD
Midodrine—Dyspepsia—Prednisone—multiple sclerosis	0.00147	0.00206	CcSEcCtD
Midodrine—Rash—Prednisolone—multiple sclerosis	0.00145	0.00204	CcSEcCtD
Midodrine—Dermatitis—Prednisolone—multiple sclerosis	0.00144	0.00203	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00144	0.00203	CcSEcCtD
Midodrine—Headache—Prednisolone—multiple sclerosis	0.00144	0.00202	CcSEcCtD
Midodrine—Confusional state—Methotrexate—multiple sclerosis	0.0014	0.00198	CcSEcCtD
Midodrine—Dizziness—Triamcinolone—multiple sclerosis	0.00139	0.00196	CcSEcCtD
Midodrine—Dizziness—Methylprednisolone—multiple sclerosis	0.00139	0.00196	CcSEcCtD
Midodrine—Feeling abnormal—Prednisone—multiple sclerosis	0.00137	0.00193	CcSEcCtD
Midodrine—Asthenia—Dexamethasone—multiple sclerosis	0.00137	0.00193	CcSEcCtD
Midodrine—Asthenia—Betamethasone—multiple sclerosis	0.00137	0.00193	CcSEcCtD
Midodrine—Nervous system disorder—Methotrexate—multiple sclerosis	0.00137	0.00192	CcSEcCtD
Midodrine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00136	0.00192	CcSEcCtD
Midodrine—Nausea—Prednisolone—multiple sclerosis	0.00136	0.00192	CcSEcCtD
Midodrine—Pruritus—Betamethasone—multiple sclerosis	0.00135	0.00191	CcSEcCtD
Midodrine—Pruritus—Dexamethasone—multiple sclerosis	0.00135	0.00191	CcSEcCtD
Midodrine—Skin disorder—Methotrexate—multiple sclerosis	0.00135	0.0019	CcSEcCtD
Midodrine—Rash—Triamcinolone—multiple sclerosis	0.00133	0.00187	CcSEcCtD
Midodrine—Dermatitis—Triamcinolone—multiple sclerosis	0.00133	0.00187	CcSEcCtD
Midodrine—Rash—Methylprednisolone—multiple sclerosis	0.00133	0.00187	CcSEcCtD
Midodrine—Dermatitis—Methylprednisolone—multiple sclerosis	0.00133	0.00187	CcSEcCtD
Midodrine—Headache—Triamcinolone—multiple sclerosis	0.00132	0.00186	CcSEcCtD
Midodrine—Headache—Methylprednisolone—multiple sclerosis	0.00132	0.00186	CcSEcCtD
Midodrine—Abdominal pain—Prednisone—multiple sclerosis	0.00132	0.00185	CcSEcCtD
Midodrine—Dizziness—Dexamethasone—multiple sclerosis	0.00127	0.00178	CcSEcCtD
Midodrine—Dizziness—Betamethasone—multiple sclerosis	0.00127	0.00178	CcSEcCtD
Midodrine—Insomnia—Methotrexate—multiple sclerosis	0.00126	0.00177	CcSEcCtD
Midodrine—Nausea—Triamcinolone—multiple sclerosis	0.00125	0.00176	CcSEcCtD
Midodrine—Paraesthesia—Methotrexate—multiple sclerosis	0.00125	0.00176	CcSEcCtD
Midodrine—Nausea—Methylprednisolone—multiple sclerosis	0.00125	0.00176	CcSEcCtD
Midodrine—Dyspnoea—Methotrexate—multiple sclerosis	0.00124	0.00175	CcSEcCtD
Midodrine—Somnolence—Methotrexate—multiple sclerosis	0.00124	0.00174	CcSEcCtD
Midodrine—Dyspepsia—Methotrexate—multiple sclerosis	0.00123	0.00173	CcSEcCtD
Midodrine—Rash—Dexamethasone—multiple sclerosis	0.00121	0.0017	CcSEcCtD
Midodrine—Rash—Betamethasone—multiple sclerosis	0.00121	0.0017	CcSEcCtD
Midodrine—Dermatitis—Dexamethasone—multiple sclerosis	0.00121	0.0017	CcSEcCtD
Midodrine—Dermatitis—Betamethasone—multiple sclerosis	0.00121	0.0017	CcSEcCtD
Midodrine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.0012	0.00169	CcSEcCtD
Midodrine—Headache—Betamethasone—multiple sclerosis	0.0012	0.00169	CcSEcCtD
Midodrine—Headache—Dexamethasone—multiple sclerosis	0.0012	0.00169	CcSEcCtD
Midodrine—Asthenia—Prednisone—multiple sclerosis	0.0012	0.00168	CcSEcCtD
Midodrine—Pain—Methotrexate—multiple sclerosis	0.00119	0.00168	CcSEcCtD
Midodrine—Pruritus—Prednisone—multiple sclerosis	0.00118	0.00166	CcSEcCtD
Midodrine—Feeling abnormal—Methotrexate—multiple sclerosis	0.00115	0.00162	CcSEcCtD
Midodrine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00114	0.0016	CcSEcCtD
Midodrine—Nausea—Dexamethasone—multiple sclerosis	0.00114	0.0016	CcSEcCtD
Midodrine—Nausea—Betamethasone—multiple sclerosis	0.00114	0.0016	CcSEcCtD
Midodrine—Dizziness—Prednisone—multiple sclerosis	0.0011	0.00155	CcSEcCtD
Midodrine—Abdominal pain—Methotrexate—multiple sclerosis	0.0011	0.00155	CcSEcCtD
Midodrine—Rash—Prednisone—multiple sclerosis	0.00105	0.00148	CcSEcCtD
Midodrine—Dermatitis—Prednisone—multiple sclerosis	0.00105	0.00148	CcSEcCtD
Midodrine—Headache—Prednisone—multiple sclerosis	0.00104	0.00147	CcSEcCtD
Midodrine—Asthenia—Methotrexate—multiple sclerosis	0.000999	0.00141	CcSEcCtD
Midodrine—Nausea—Prednisone—multiple sclerosis	0.00099	0.00139	CcSEcCtD
Midodrine—Pruritus—Methotrexate—multiple sclerosis	0.000985	0.00139	CcSEcCtD
Midodrine—Dizziness—Methotrexate—multiple sclerosis	0.000921	0.0013	CcSEcCtD
Midodrine—Rash—Methotrexate—multiple sclerosis	0.000878	0.00124	CcSEcCtD
Midodrine—Dermatitis—Methotrexate—multiple sclerosis	0.000877	0.00124	CcSEcCtD
Midodrine—Headache—Methotrexate—multiple sclerosis	0.000873	0.00123	CcSEcCtD
Midodrine—Nausea—Methotrexate—multiple sclerosis	0.000827	0.00116	CcSEcCtD
Midodrine—ADRA1B—GPCR ligand binding—CXCR3—multiple sclerosis	0.000508	0.00175	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000504	0.00174	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—LINGO1—multiple sclerosis	0.000502	0.00173	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—RGS1—multiple sclerosis	0.0005	0.00173	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CXCL10—multiple sclerosis	0.000495	0.00171	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CCR2—multiple sclerosis	0.000494	0.00171	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000488	0.00169	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CCL3—multiple sclerosis	0.000486	0.00168	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000479	0.00165	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—S1PR1—multiple sclerosis	0.000474	0.00164	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCR1—multiple sclerosis	0.000474	0.00164	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCL13—multiple sclerosis	0.000474	0.00164	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—GPR65—multiple sclerosis	0.000474	0.00164	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000473	0.00163	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—PTGER4—multiple sclerosis	0.000467	0.00161	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000464	0.0016	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CNR1—multiple sclerosis	0.000456	0.00158	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—RGS1—multiple sclerosis	0.000454	0.00157	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CXCR3—multiple sclerosis	0.000451	0.00156	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000444	0.00153	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CCR2—multiple sclerosis	0.000439	0.00152	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TAGAP—multiple sclerosis	0.000435	0.0015	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000434	0.0015	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CCR1—multiple sclerosis	0.000434	0.0015	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000434	0.0015	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—GPR65—multiple sclerosis	0.00043	0.00149	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CCL5—multiple sclerosis	0.000426	0.00147	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000421	0.00145	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000418	0.00144	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—LINGO1—multiple sclerosis	0.000416	0.00144	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000412	0.00142	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CXCL10—multiple sclerosis	0.000411	0.00142	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CNR1—multiple sclerosis	0.000405	0.0014	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—RGS1—multiple sclerosis	0.000403	0.00139	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000394	0.00136	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCR1—multiple sclerosis	0.000394	0.00136	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCL13—multiple sclerosis	0.000394	0.00136	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000392	0.00135	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000385	0.00133	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000385	0.00133	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000385	0.00133	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CCR5—multiple sclerosis	0.000384	0.00133	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—GPR65—multiple sclerosis	0.000382	0.00132	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—S1PR1—multiple sclerosis	0.00038	0.00131	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000372	0.00128	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—LINGO1—multiple sclerosis	0.00037	0.00128	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GPC5—multiple sclerosis	0.00037	0.00128	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000365	0.00126	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TAGAP—multiple sclerosis	0.000361	0.00125	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000358	0.00124	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CCL5—multiple sclerosis	0.000354	0.00122	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.00035	0.00121	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCR1—multiple sclerosis	0.00035	0.00121	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000348	0.0012	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000346	0.00119	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCL3—multiple sclerosis	0.000338	0.00117	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CCR2—multiple sclerosis	0.000337	0.00116	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000327	0.00113	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PTGER4—multiple sclerosis	0.000325	0.00112	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RGS1—multiple sclerosis	0.000323	0.00112	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TAGAP—multiple sclerosis	0.000321	0.00111	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00032	0.0011	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CCR5—multiple sclerosis	0.000319	0.0011	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—S1PR1—multiple sclerosis	0.000315	0.00109	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCR3—multiple sclerosis	0.000314	0.00109	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CCL5—multiple sclerosis	0.000314	0.00108	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CNR1—multiple sclerosis	0.000311	0.00107	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GPC5—multiple sclerosis	0.000307	0.00106	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GPR65—multiple sclerosis	0.000306	0.00106	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—SRM—multiple sclerosis	0.000306	0.00106	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCR2—multiple sclerosis	0.000306	0.00106	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000301	0.00104	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—POMC—multiple sclerosis	0.0003	0.00104	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000297	0.00103	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000297	0.00102	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—CCL2—multiple sclerosis	0.000293	0.00101	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00029	0.001	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000287	0.000992	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000284	0.000981	CbGpPWpGaD
Midodrine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	0.000284	0.00098	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CCR5—multiple sclerosis	0.000283	0.000977	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CNR1—multiple sclerosis	0.000282	0.000974	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCL3—multiple sclerosis	0.000281	0.000969	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—S1PR1—multiple sclerosis	0.00028	0.000968	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCL13—multiple sclerosis	0.00028	0.000968	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCR1—multiple sclerosis	0.00028	0.000968	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00028	0.000966	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CCR2—multiple sclerosis	0.000279	0.000965	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GPC5—multiple sclerosis	0.000273	0.000941	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PTGER4—multiple sclerosis	0.00027	0.000933	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RGS1—multiple sclerosis	0.000268	0.000926	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000264	0.000912	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCR3—multiple sclerosis	0.000261	0.000901	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CNR1—multiple sclerosis	0.000258	0.00089	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000255	0.000881	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GPR65—multiple sclerosis	0.000254	0.000878	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CXCL10—multiple sclerosis	0.000254	0.000877	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCR2—multiple sclerosis	0.000254	0.000876	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00025	0.000862	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	0.000249	0.00086	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—POMC—multiple sclerosis	0.000249	0.00086	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	0.000248	0.000857	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—CCL2—multiple sclerosis	0.000244	0.000841	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CCL5—multiple sclerosis	0.000241	0.000831	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	0.00024	0.000828	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	0.000238	0.000823	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CNR1—multiple sclerosis	0.000234	0.000809	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR1—multiple sclerosis	0.000233	0.000803	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL13—multiple sclerosis	0.000233	0.000803	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000232	0.000802	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	0.000232	0.0008	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000231	0.000798	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000229	0.000791	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	0.000226	0.00078	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	0.000225	0.000778	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000222	0.000766	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	0.000221	0.000764	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCL5—multiple sclerosis	0.000219	0.000755	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—CCR5—multiple sclerosis	0.000217	0.000749	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	0.000216	0.000747	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	0.000216	0.000745	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	0.000216	0.000745	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000214	0.000738	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000211	0.000728	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	0.000208	0.000718	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	0.000207	0.000713	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	0.000207	0.000713	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000206	0.000712	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CCL5—multiple sclerosis	0.0002	0.00069	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL3—multiple sclerosis	0.0002	0.000689	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GPC5—multiple sclerosis	0.000197	0.000682	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCR5—multiple sclerosis	0.000197	0.00068	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL2RA—multiple sclerosis	0.000194	0.00067	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PTGER4—multiple sclerosis	0.000192	0.000664	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000192	0.000663	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PGR—multiple sclerosis	0.000189	0.000654	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000187	0.000647	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCR3—multiple sclerosis	0.000186	0.000641	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CD28—multiple sclerosis	0.000184	0.000635	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCL5—multiple sclerosis	0.000181	0.000627	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCR2—multiple sclerosis	0.000181	0.000624	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—CCR5—multiple sclerosis	0.00018	0.000622	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000177	0.000613	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000177	0.000613	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.00017	0.000589	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—POMC—multiple sclerosis	0.00017	0.000585	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CNR1—multiple sclerosis	0.000167	0.000575	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL3—multiple sclerosis	0.000166	0.000572	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—RRM1—multiple sclerosis	0.000164	0.000565	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	0.000163	0.000565	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	0.000161	0.000557	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	0.000161	0.000556	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	0.00016	0.000552	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	0.00016	0.000551	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000158	0.000544	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	0.000157	0.000543	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	0.000154	0.000532	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—POMC—multiple sclerosis	0.000154	0.000532	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	0.000153	0.000527	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—CCL2—multiple sclerosis	0.000151	0.00052	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CXCL10—multiple sclerosis	0.00015	0.000518	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	0.00015	0.000518	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	0.000147	0.000508	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	0.000145	0.000501	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000143	0.000494	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	0.000142	0.000489	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	0.000141	0.000486	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	0.00014	0.000482	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	0.000138	0.000478	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	0.000137	0.000473	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	0.000137	0.000472	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	0.000136	0.000468	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	0.000133	0.00046	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	0.000131	0.000453	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	0.000129	0.000446	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	0.000128	0.000441	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	0.000125	0.000433	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	0.000125	0.000432	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	0.000125	0.000432	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	0.000125	0.00043	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	0.000123	0.000424	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	0.00012	0.000413	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	0.000116	0.000402	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	0.000115	0.000396	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	0.000114	0.000393	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	0.000114	0.000392	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	0.000113	0.000392	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	0.000111	0.000383	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	0.000111	0.000382	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	0.000109	0.000376	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	0.000107	0.00037	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	0.000106	0.000366	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	0.000104	0.000359	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	0.000101	0.000348	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	9.93e-05	0.000343	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	9.67e-05	0.000334	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	9.66e-05	0.000334	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	9.57e-05	0.000331	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	9.52e-05	0.000329	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	9.52e-05	0.000329	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	9.45e-05	0.000326	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—BCHE—multiple sclerosis	9.39e-05	0.000324	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	9.24e-05	0.000319	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	9.09e-05	0.000314	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	8.9e-05	0.000307	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	8.82e-05	0.000305	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	8.79e-05	0.000303	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	8.71e-05	0.000301	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	8.58e-05	0.000296	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	8.45e-05	0.000292	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	8.39e-05	0.00029	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	8.08e-05	0.000279	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	7.94e-05	0.000274	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	7.8e-05	0.00027	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	7.55e-05	0.000261	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	7.38e-05	0.000255	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	7.23e-05	0.00025	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	7.06e-05	0.000244	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	6.72e-05	0.000232	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	6.71e-05	0.000232	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	6.7e-05	0.000232	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	6.69e-05	0.000231	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	6.56e-05	0.000227	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	6.42e-05	0.000222	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	6.36e-05	0.00022	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	5.96e-05	0.000206	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	5.66e-05	0.000195	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOE—multiple sclerosis	5.65e-05	0.000195	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	5.58e-05	0.000193	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	5.55e-05	0.000192	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	5.28e-05	0.000182	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	5.26e-05	0.000182	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	5.24e-05	0.000181	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	5.14e-05	0.000178	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	4.96e-05	0.000171	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	4.93e-05	0.00017	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—POMC—multiple sclerosis	4.85e-05	0.000168	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	4.7e-05	0.000162	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	4.69e-05	0.000162	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ALB—multiple sclerosis	4.43e-05	0.000153	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	4.36e-05	0.000151	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	4.35e-05	0.00015	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	4.27e-05	0.000147	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	4.17e-05	0.000144	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	3.95e-05	0.000136	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	3.88e-05	0.000134	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	3.87e-05	0.000134	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	3.79e-05	0.000131	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	3.28e-05	0.000113	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	2.91e-05	0.000101	CbGpPWpGaD
